You are here: Industry Insights > Catalent

News List

Catalent opens second clinical supply facility in Shanghai fiercepharma
April 14, 2019
With drug development among both Chinese and Western biotechs and drugmakers escalating rapidly, Catalent has doubled down on its clinical supply capabilities in Shanghai.
Catalent Expands OptiMelt Capabilities at Somerset CoE contractpharma
April 09, 2019
Catalent Expands OptiMelt Capabilities at Somerset CoE
Catalent invests over $27 million to commercialize Zydis Ultra cphi-online
March 12, 2019
Zydis Ultra allows a patented and innovative drug coating to be introduced during a product’s formulation, enabling the dosage of active ingredient to be up to four times higher than a conventional Zydis ODT.
Adial Pharmaceuticals Announces Partnership with Catalent to Package and Distribute Adial’s AD04 for its Phase 3 Trial pharmafocusasia
February 22, 2019
Adial Pharmaceuticals, Inc www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction...
Catalent expands clinical packaging capabilities in Shanghai, China cphi-online
December 03, 2018
Catalent Pharma Solutions has announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage and is scheduled to be completed by the end of 2018.
Catalent Expands Shanghai Clinical Packaging Capabilities contractpharma
November 28, 2018
Catalent Pharma Solutions began work to expand its primary packaging capabilities at its clinical facility in Shanghai, China, which is scheduled to be completed by the end of 2018.
Catalent to Open Second Clinical Supply Facility in China contractpharma
November 14, 2018
Catalent to Open Second Clinical Supply Facility in China
Catalent signs commercial supply agreement for Aucta Pharmaceuticals' vigabatrin cphi-online
September 10, 2018
Novel dosage form employs Catalent’s proprietary stick pack dosage form.
M&As this week: Catalent, CVC, Bain Capital Private Equity pharmaceutical-technology
July 12, 2018
Catalent has agreed to acquire Juniper Pharmaceuticals, along with its Juniper Pharma Services division based in Nottingham, UK.
Catalent to buy speciality healthcare firm Juniper Pharmaceuticals pharmaceutical-technology
July 12, 2018
US-based drug delivery technology company Catalent has agreed to purchase all outstanding shares of specialty healthcare firm Juniper Pharmaceuticals for a total cash consideration of $139.6m, which represents $11.50 per share.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page